Medlab Clinical: Edison Open House Healthcare 2022

Published on 9 February 2022

Medlab Clinical is an Australian biotechnology company that is developing therapeutics using its proprietary delivery platform NanoCelle. Its most advanced programme is in cancer pain management with lead drug candidate NanaBis, a medicinal cannabis product for cancer-related bone pain.

• Please tell us more about the recent change in focus from a nutraceutical to a biotech business.
• What is NanoCelle and what does it do?
• Are there any potential issues with the NanoCelle technology?
• What kind of compounds are you focusing on at present and what would you say is your leading contender?
• Do you think your Australian compassionate programme might be replicated in other countries?
• What are the timelines for the clinical development of NanaBis?
• Have you seen any impact on your workflow from COVID-19?
• Following the recent addition of the US patent for NanoCelle, what is your current patent portfolio?

Share this with friends and colleagues